Shares

15 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Feb 09, 2024

SELL
$306.88 - $380.0 $4,910 - $6,080
-16 Reduced 11.51%
123 $46,000
Q3 2023

Oct 27, 2023

SELL
$315.92 - $397.36 $12,952 - $16,291
-41 Reduced 22.78%
139 $44,000
Q2 2023

Aug 11, 2023

SELL
$346.15 - $392.09 $455,533 - $515,990
-1,316 Reduced 87.97%
180 $69,000
Q1 2023

May 05, 2023

SELL
$323.56 - $373.36 $80,890 - $93,340
-250 Reduced 14.32%
1,496 $558,000
Q4 2022

Feb 10, 2023

SELL
$248.67 - $334.17 $7.97 Million - $10.7 Million
-32,041 Reduced 94.83%
1,746 $576,000
Q3 2022

Nov 01, 2022

SELL
$263.81 - $337.27 $653,457 - $835,417
-2,477 Reduced 6.83%
33,787 $8.92 Million
Q2 2022

Aug 03, 2022

BUY
$301.4 - $428.42 $333,649 - $474,260
1,107 Added 3.15%
36,264 $11.4 Million
Q1 2022

May 13, 2022

SELL
$379.46 - $424.54 $612,827 - $685,632
-1,615 Reduced 4.39%
35,157 $14.7 Million
Q4 2021

Feb 14, 2022

SELL
$373.53 - $434.12 $30.4 Million - $35.3 Million
-81,336 Reduced 68.87%
36,772 $15.4 Million
Q3 2021

Nov 12, 2021

BUY
$396.76 - $455.92 $46.9 Million - $53.8 Million
118,108 New
118,108 $48.8 Million
Q3 2019

Nov 13, 2019

SELL
$294.25 - $341.49 $10,298 - $11,952
-35 Closed
0 $0
Q1 2018

May 16, 2018

SELL
$218.74 - $251.43 $2,624 - $3,017
-12 Reduced 25.53%
35 $8,000
Q4 2017

Feb 13, 2018

SELL
$217.88 - $244.43 $6,536 - $7,332
-30 Reduced 38.96%
47 $10,000
Q3 2017

Nov 08, 2017

BUY
$231.6 - $253.39 $17,370 - $19,004
75 Added 3750.0%
77 $18,000
Q4 2015

Sep 15, 2017

BUY
N/A
2
2 $0

Others Institutions Holding COO

About COOPER COMPANIES, INC.


  • Ticker COO
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Instruments & Supplies
  • Shares Outstandng 49,346,000
  • Market Cap $4.92B
  • Description
  • The Cooper Companies, Inc., together with its subsidiaries, develops, manufactures, and markets contact lens wearers. The company operates in two segments, CooperVision and CooperSurgical. The CooperVision segment offers spherical lense, including lenses that correct near and farsightedness; and toric and multifocal lenses comprising lenses corr...
More about COO
Track This Portfolio

Track Assetmark, Inc Portfolio

Follow Assetmark, Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Assetmark, Inc, based on Form 13F filings with the SEC.

News

Stay updated on Assetmark, Inc with notifications on news.